Max Kates, M.D. Timonium, MD 21093

Max Kates, M.D. is a leading institution located in Timonium, Maryland, United States, specializing in urologic oncology. Dr. Max Kates, an Associate Professor of Urology and Oncology, heads the Division of Urologic Oncology at the prestigious Brady Urological Institute. With expertise in bladder and prostate cancer, Dr. Kates offers personalized treatment plans utilizing open, endoscopic, and robotic surgical approaches. He is dedicated to open communication with patients, their families, and referring providers to ensure a speedy recovery.

As the clinical director of the bladder cancer multidisciplinary clinic at Johns Hopkins Greenberg Bladder Cancer Institute, Dr. Kates collaborates with a team to deliver cutting-edge precision medicine approaches for bladder cancer patients. His research interests focus on novel treatments for urinary tract cancers, with over 135 journal articles to his credit. Dr. Kates is also the principal investigator on multiple trials, including the groundbreaking EA8212 BRIDGE trial comparing BCG to GemDoce chemotherapy for early stage bladder cancer.

Patients have rated Dr. Kates highly on the national CG-CAHPS Medical Practice patient experience survey, with comments praising his expertise and compassionate care. Masks are strongly recommended but not required at the institution, and patients are advised to anticipate delays when traveling to appointments due to the recent collapse of the Francis Scott Key Bridge in the Baltimore region. For those seeking state-of-the-art urologic oncology care, Max Kates, M.D. is a trusted choice.